Hans C. Andersson, MD | HRSA Southeast Regional Genetics Network

Hans C. Andersson, MD

SERN Workgroups & Committees

Telemedicine Workgroup

Roles

Academic Contact

Biochem Lab

Diagnostic Lab Director

Medical Geneticist

Centers & Contact Information

Womens and Childrens Hospital, General Genetics Clinic
Lafayette, LA

Biography

Hans C. Andersson, MD is the Karen Gore Chair of Human Genetics and Director of the Hayward Genetics Center at the Tulane University Medical School where he directs the Biochemical Genetics Lab. Dr. Andersson is the past President of the SouthEast Regional Genetics Group (SERGG), holds membership of numerous national societies including the Society of Pediatric Research and is a member of the Editorial Board of the Journal of Pediatrics. He is past Co-Chair of the National Coordinating Center Telegenetics Workgroup and a current CO-PI of the Southeast Regional Genetics Network (SERN).

Selected Publications

Selected Publications by the Presenter
(from a total of 50 publications)

Andersson HC, Kratz L, Kelley R^.Desmosterolosis Presenting with Multiple Congenital Anomalies and Profound Developmental Delay. Am J Med Genet 113:315-319, 2002.

Andersson HC, MA Krousel-Wood, KE Jackson, J Rice, IM Lubin.Medical Genetic Test Reporting in Molecular Cystic Fibrosis and Factor V Leiden Tests Based On Reports Solicited From North American Laboratories. Gen in Med 4(5):324-7 2002.

Andersson HC, Charrow J, Kaplan P, Mistry P, Pastores G, Prakesh-Cheng A, Rosenbloom BE, Scott R, Wappner RS, Weinreb NJ. Individualization of Long-term Enzyme Replacement Therapy for Gaucher Disease. Genet in Med Feb 7:105-110, 2005.

Andersson HC, Narumanchi TC, Cunningham A, Bowdish B, Thoene J. Genetic/Metabolic Health Care Delivery During and After Katrina and Rita, Molecular Genetics and Metabolism, 88:3-6, 2006.

Andersson HC, Kaplan P, Kacena K, J Yee. Eight-year clinical outcomes of long-term enzyme replacement therapy in 884 children with type 1 Gaucher disease, Pediatrics 2008; 122;1182-1190.

Andersson HC, Kaplan P, Kacena K, J Yee. Eight-year clinical outcomes of long-term enzyme replacement therapy in 884 children with type 1 Gaucher disease, Pediatr,122:1182, 2008

Andersson, Perry W, Bowdish B, P Floyd-Browning. Emergency preparedness for genetics centers, laboratories and patients: the SouthEast Region Genetics Collaborative strategic plan. Genet Med, ePub: June, 2011, October, 2011.